Skip to main content

Plaque Psoriasis News (Page 5)

LEO Pharma Announces U.S. Approval of Enstilar Foam (calcipotriene/betamethasone dipropionate) for Plaque Psoriasis

Ballerup, Denmark 19 October, 2015: LEO Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved Enstilar (calcipotriene/betamethasone dipropionate 50 micrograms/g / 0,5...

FDA Approves Cosentyx (secukinumab) for Plaque Psoriasis

January 21, 2015 – The U.S. Food and Drug Administration today approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis. Psoriasis is a skin condition that causes...

FDA Approves Otezla (apremilast) for Moderate to Severe Plaque Psoriasis

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla (apremilast), the Company's oral, selective inhibitor of...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Psoriasis

Related drug support groups

methylprednisolone, Humira, Enbrel, Remicade, Stelara, Otezla, Cosentyx, Skyrizi, dexamethasone, view more... adalimumab, etanercept, halobetasol, Taltz, ustekinumab, Cimzia, Tremfya, Ilumya